Plan your future with our Retirement Budget Calculator

CHA₂DS₂-VASc Stroke Risk Score Calculator

Select your risk factors below to calculate your CHA₂DS₂-VASc score, estimated annual stroke risk percentage, and evidence-based anticoagulation recommendations.
Loading...
Luis GonzalezCreated by Luis GonzalezLast updated:

How to Use This Calculator

  1. 1

    Indicate Congestive Heart Failure (CHF)

    Select 'Yes' if the patient has a history of congestive heart failure. This adds 1 point to the score.

  2. 2

    Report Hypertension

    Select 'Yes' if the patient has a history of high blood pressure (hypertension). This adds 1 point.

  3. 3

    Specify Age ≥75 Years

    Select 'Yes' if the patient is 75 years old or older. This is a significant risk factor, adding 2 points.

  4. 4

    Note Diabetes Mellitus

    Select 'Yes' if the patient has diabetes. This adds 1 point to the score.

  5. 5

    Identify Prior Stroke / TIA / Thromboembolism

    Select 'Yes' if there's a history of stroke, transient ischemic attack (TIA), or other thromboembolism. This is a critical factor, adding 2 points.

  6. 6

    Confirm Vascular Disease

    Select 'Yes' if the patient has vascular disease (e.g., prior myocardial infarction, peripheral artery disease, aortic plaque). This adds 1 point.

  7. 7

    Specify Age 65–74 Years

    Select 'Yes' if the patient is between 65 and 74 years old. This adds 1 point.

  8. 8

    Report Female Sex

    Select 'Yes' if the patient is female. This adds 1 point.

  9. 9

    Review the stroke risk

    The calculator will display the total CHA₂DS₂-VASc score, estimated annual stroke risk, and anticoagulation guidance.

Example Calculation

A clinician assesses a male patient with atrial fibrillation who has a history of congestive heart failure, hypertension, and vascular disease, and is 68 years old.

Congestive Heart Failure (CHF)

Yes (1 point)

Hypertension

Yes (1 point)

Age ≥75 Years

No (0 points)

Diabetes Mellitus

No (0 points)

Prior Stroke / TIA / Thromboembolism

No (0 points)

Vascular Disease

Yes (1 point)

Age 65–74 Years

Yes (1 point)

Female Sex

No / Male (0 points)

Results

4

Tips

Regular Reassessment is Key

A patient's CHA₂DS₂-VASc score can change over time as new risk factors develop or existing ones are managed. Regular reassessment, typically annually or after significant clinical events, is crucial for updating stroke risk and treatment plans.

CHA₂DS₂-VASc is for AFib

Remember that the CHA₂DS₂-VASc score is specifically validated for assessing stroke risk in patients with non-valvular atrial fibrillation. It should not be used for other conditions or populations.

Consider Bleeding Risk

While a high CHA₂DS₂-VASc score indicates a need for anticoagulation, always balance this with an assessment of bleeding risk, often using tools like the HAS-BLED score. For example, a HAS-BLED score of 3 or more indicates high bleeding risk, requiring careful consideration.

Assessing Stroke Risk: The CHA₂DS₂-VASc Score Calculator

The CHA₂DS₂-VASc Stroke Risk Score Calculator is a critical tool for healthcare professionals and patients managing atrial fibrillation (AFib). This calculator quantifies an individual's risk of stroke, providing a clear score, an estimated annual risk percentage, and essential guidance on anticoagulation therapy. Understanding this score is paramount for implementing effective stroke prevention strategies and improving patient outcomes in 2025.

Managing Atrial Fibrillation and Stroke Prevention

Atrial fibrillation (AFib) is the most common sustained cardiac arrhythmia, significantly increasing the risk of stroke. Early diagnosis and diligent management of AFib are crucial for preventing these potentially devastating events. Clinical guidelines, such as those from the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS), strongly advocate for aggressive stroke prevention strategies. These include not only lifestyle modifications (e.g., diet, exercise, smoking cessation) but, more importantly, adherence to prescribed anticoagulation medications like apixaban or rivaroxaban for eligible patients. These medications reduce the risk of blood clot formation in the heart's atria, which can then travel to the brain and cause a stroke.

The Logic Behind the CHA₂DS₂-VASc Score

The CHA₂DS₂-VASc score is a refined clinical assessment tool that assigns points based on specific stroke risk factors. Each factor contributes a designated number of points, which are then summed to yield a total score.

The factors and their point values are:

  • Congestive Heart Failure (1 point)
  • Hypertension (1 point)
  • A₂ge ≥75 Years (2 points)
  • Diabetes Mellitus (1 point)
  • S₂troke / TIA / Thromboembolism (2 points)
  • Vascular Disease (1 point)
  • Age 65–74 Years (1 point)
  • Scex Category (Female) (1 point)

The total score directly correlates with the estimated annual stroke risk, guiding clinical decisions on anticoagulation.

💡 While the CHA₂DS₂-VASc score assesses stroke risk, other health calculators help classify different medical conditions. Our Fever Severity Classifier can help understand the implications of body temperature readings.

Calculating Stroke Risk: A Clinical Example

Consider a male patient with atrial fibrillation who presents with the following history:

  • Congestive Heart Failure (CHF): Yes (1 point)
  • Hypertension: Yes (1 point)
  • Age ≥75 Years: No (0 points)
  • Diabetes Mellitus: No (0 points)
  • Prior Stroke / TIA / Thromboembolism: No (0 points)
  • Vascular Disease: Yes (1 point)
  • Age 65–74 Years: Yes (1 point)
  • Female Sex: No / Male (0 points)

Let's calculate his CHA₂DS₂-VASc score:

  1. CHF: 1 point
  2. Hypertension: 1 point
  3. Vascular Disease: 1 point
  4. Age 65–74 Years: 1 point
  5. Total Score: 1 + 1 + 1 + 1 = 4

Based on a score of 4, his estimated annual stroke risk is 4.0%, categorizing him as high risk. Oral anticoagulation would be strongly recommended, and referral to a cardiologist or stroke specialist for management review would be advised.

💡 Maintaining a healthy body composition is also crucial for overall cardiovascular wellness. The Fat Mass Calculator provides insights into body fat levels, which can impact various health risks.

Clinical Guidelines for Anticoagulation Based on CHA₂DS₂-VASc

Major cardiology organizations provide clear guidelines for initiating oral anticoagulation therapy in patients with non-valvular atrial fibrillation, primarily driven by the CHA₂DS₂-VASc score. The European Society of Cardiology (ESC) and American Heart Association/American College of Cardiology (AHA/ACC) guidelines generally recommend:

  • Score 0 (males) or 1 (females with only female sex as a risk factor): No antithrombotic therapy is recommended, as the annual stroke risk is very low (<1%).
  • Score 1 (males) or 2 (females): Oral anticoagulation should be considered, as the annual stroke risk becomes clinically meaningful (e.g., 1.3% for males with score 1). Shared decision-making with the patient is often encouraged.
  • Score ≥2 (males) or ≥3 (females): Oral anticoagulation is strongly recommended, as the annual stroke risk is significantly elevated (e.g., 2.2% for males with score 2, 3.2% for males with score 3). For patients in this category, the benefits of stroke prevention typically outweigh the risks of bleeding. These guidelines are regularly updated, and clinicians must refer to the most current recommendations.

Frequently Asked Questions

What does CHA₂DS₂-VASc stand for?

CHA₂DS₂-VASc is an acronym where each letter or number represents a specific risk factor for stroke in patients with atrial fibrillation. It stands for Congestive Heart Failure, Hypertension, Age ≥75 (doubled), Diabetes, Stroke/TIA/Thromboembolism (doubled), Vascular disease, Age 65–74, and Sex Category (female). Each factor contributes points to a total score.

How is the CHA₂DS₂-VASc score used in clinical practice?

The CHA₂DS₂-VASc score is a clinical prediction rule used to estimate the risk of stroke in patients with non-valvular atrial fibrillation. The total score guides decisions regarding antithrombotic therapy, with higher scores indicating a greater need for oral anticoagulation to prevent thromboembolic events. It helps clinicians stratify patients and personalize treatment.

Does a CHA₂DS₂-VASc score of 0 or 1 mean no stroke risk?

A CHA₂DS₂-VASc score of 0 for males or 1 for females (where the only risk factor is female sex) indicates a very low annual stroke risk (typically <1%). In these cases, antithrombotic therapy is generally not recommended. However, no score means zero risk, and clinicians always consider individual patient circumstances and potential changes in risk factors.